Clinical trial Recruiting at 1 site Observational Ages 18 to 49 Women only

Evaluating the convenience of natural cycle frozen embryo transfer

Official title: Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer: an Ambispective Cohort Study

Run by Instituto Valenciano de Infertilidade de Lisboa · NCT06307184 · Data updated 2026-11-12

This study looks at whether a new method for frozen embryo transfer that uses the body's natural cycle is easier and more convenient for patients compared to the traditional method that relies on medication.

More Frozen Embryo Transfer (FET) trials

Quick facts

Study typeObservational
Ages18 Years to 49 Years
SexWomen only
Enrollment530 (estimated)
SponsorInstituto Valenciano de Infertilidade de Lisboa
Research network
Locations1 site (Lisbon)
StatusRecruiting
StartedFebruary 23, 2024
Main results expectedSeptember 2026
Study endsDecember 2026
Registry record updatedFebruary 23, 2026
Trial IDNCT06307184 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women with regular menstrual cycles who are undergoing their first or second frozen embryo transfer using a single blastocyst from donated oocytes.

Probably not a fit

Patients who have a history of recurrent pregnancy loss or implantation failure, or those requiring exogenous ovarian stimulation during the transfer, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the convenience of the natural proliferative phase frozen embryo transfer (NPP-FET) protocol by analyzing the number of appointments required before scheduling the transfer. The study compares NPP-FET with traditional artificial cycle frozen embryo transfer (AC-FET), which is often preferred for its scheduling ease despite potential risks associated with it. The research focuses on patients undergoing frozen embryo transfer in assisted reproductive technology (ART) clinics, particularly those using donated oocytes. By examining the convenience and outcomes of NPP-FET, the study seeks to provide insights into optimizing embryo transfer protocols.

Why it matters

Potential benefit: If successful, this study could lead to a more convenient and effective approach for patients undergoing frozen embryo transfers, potentially improving pregnancy outcomes.

How similar studies have gone: While there is growing evidence supporting the use of natural cycle protocols, this specific approach of NPP-FET is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Endometrial thickness ≥ 7 mm on the day of starting progesterone-based luteal phase support (LPS)
* Serum progesterone levels \<1.5 ng/ml on the day of starting progesterone-based LPS
* LPS with micronized progesterone 400mg b.i.d.
* Regular cycles (\>24 days, ≤ 38 days)
* IVF/ICSI with donated oocytes
* Single blastocyst stage embryo transfer
* First or second embryo transfer from the same cohort

Exclusion Criteria:

* Use of exogenous ovarian stimulation during FET
* Untreated hydrosalpinx, polyp, submucous myomas or severe adenomyosis
* Recurrent pregnancy loss (≥ 3 previous pregnancy losses)
* Recurrent implantation failure with embryos from oocyte donation (≥ 3 previous failed embryo transfers)
* Personalized initiation of exogenous progesterone according to a previous endometrial receptivity assay test

Where it's running

  • Instituto Valenciano de Infertilidade
    Lisbon, Portugal
    Recruiting

Study contacts

  • Principal investigator: Ana R Neves, MP — Instutito Valenciano de Infertilidade de Lisboa (IVI-RMA Lisboa)
  • Study coordinator: Ana R Neves, MD, PhD
  • Email: ana.neves@ivirma.com
  • Phone: 218 503 210

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.